Ensign Peak Advisors
TSVT

Ensign Peak Advisors’s 2seventy bio TSVT Stock Holding History

Ensign Peak Advisors’s Portfolio TSVT Stock Details TSVT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-11,633
Closed -$169K – 2198
2022
Q3 		$169K Buy
11,633
+4,430
+62% +$65.8K ﹤0.01% 1935
2022
Q2 		$95K Hold
7,203
– – ﹤0.01% 1970
2022
Q1 		$123K Hold
7,203
– – ﹤0.01% 1992
2021
Q4 		$185K Buy
+7,203
New +$225K ﹤0.01% 1940

Other funds holding TSVT

Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
CC
Casdin Capital New York $1.32B AUM 76.62% 1-Year Est. Return
BCLSI
Bain Capital Life Sciences Investors Boston, Massachusetts $1.11B AUM 171.34% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
MAP
Madison Avenue Partners New York $2.3B AUM 115.82% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return

Ensign Peak Advisors's TSVT Position: Q4 2022 in Review

Ensign Peak Advisors sold out of 2seventy bio (TSVT) in Q4 2022, closing a stake of 11,633 shares — an estimated $169K sold.

Ensign Peak Advisors first reported a position in TSVT in Q4 2021 and held it in 4 quarters. The position peaked at $185K in Q4 2021. 141 funds tracked by Wall St. Rank hold TSVT as of Q4 2022.

  • Ensign Peak Advisors reported no remaining 2seventy bio position as of Q4 2022 after selling out during the quarter.
  • Ensign Peak Advisors sold 11,633 2seventy bio shares in Q4 2022, an estimated $169K.
  • Ensign Peak Advisors first reported a position in 2seventy bio in Q4 2021 and held it in 4 quarters.
  • Ensign Peak Advisors's 2seventy bio position peaked at $185K in Q4 2021.
  • 141 funds tracked by Wall St. Rank held 2seventy bio as of Q4 2022.

Based on Ensign Peak Advisors's 13F filing for Q4 2022, filed 13 Feb 2023.